ATRION CORP
atrioncorp.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Aug 9, 2024. Its latest SEC filing is a SC 13G/A from Nov 14, 2024.
10-Q for Q2 FY2024, filed Aug 9, 2024
The sections below describe the company as of the FY2023 annual report.
What Did They Do?
Makes fluid-delivery products, including valves and infection-control devices, for hospitals and home healthcare providers, and cardiovascular and ophthalmic devices for equipment makers and healthcare providers.
10-K for FY2023, filed Feb 29, 2024Our fluid delivery products accounted for 42 percent of net revenues for 2023, 46 percent for 2022, and 47 percent for 2021. We have…View ↗
Our cardiovascular products accounted for 41 percent of net revenues for 2023, 37 percent for 2022, and 34 percent for 2021. At the core of…View ↗
Our ophthalmic products accounted for 5 percent of net revenues for 2023, 3 percent for 2022, and 4 percent for 2021. We manufacture a…View ↗
We market components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians…View ↗
How Did They Make Money?
Atrion sells components to equipment makers and finished devices to healthcare providers; most sales are made on purchase orders, and payment is generally due after customers receive the products.
10-K for FY2023, filed Feb 29, 2024We market components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians…View ↗
More than 98 percent of our total revenue in the periods presented herein is pursuant to shipments initiated by an accepted purchase order…View ↗
Our payment terms vary by the type and location of our customers and the products or services offered, and payment is generally required…View ↗
$169.3M
-
10-K for FY2023, filed Mar 1, 2024
$169.3M ↗
Who Were Their Customers?
Atrion sells components to equipment manufacturers and finished devices to physicians, hospitals, clinics, and other treatment centers through its direct sales staff, independent representatives, and distributors.
10-K for FY2023, filed Feb 29, 2024We market components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians…View ↗
Did Revenues Turn Into Profits?
Yes. It kept 11 cents of every revenue dollar as net income in FY2023, but spent more cash than it brought in: free cash flow was −$2.3K.
10-K for FY2023, filed Mar 1, 2024
$22.6KView ↗
10-K for FY2023, filed Mar 1, 2024
$19.4MView ↗
10-K for FY2023, filed Mar 1, 2024
−$2.3KView ↗
How Were They Changing?
-
Aug 21, 2024
Nordson completed its acquisition of Atrion
Atrion became a wholly owned subsidiary, and the company requested that its shares be delisted from Nasdaq.
Sources
8-K, filed Aug 21, 2024
As described in the Introductory Note of this Current Report on Form 8-K, on August 21, 2024, the Merger was completed. Upon the…View ↗
Grew. Revenue grew 9% in 4 years, from $155.1M in FY2019 to $169.3M in FY2023, about 2% a year.
Loading...
